FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164634909> ?p ?o ?g. }

• W2164634909 endingPage "951" @default.
• W2164634909 startingPage "943" @default.
• W2164634909 abstract "It is generally assumed that the biodistribution and pharmacokinetics of radiolabelled antibodies remain similar between dosimetric and therapeutic injections in radioimmunotherapy. However, circulation half-lives of unlabelled rituximab have been reported to increase progressively after the weekly injections of standard therapy doses. The aim of this study was to evaluate the evolution of the pharmacokinetics of repeated 131I-rituximab injections during treatment with unlabelled rituximab in patients with non-Hodgkin's lymphoma (NHL).Patients received standard weekly therapy with rituximab (375 mg/m2) for 4 weeks and a fifth injection at 7 or 8 weeks. Each patient had three additional injections of 185 MBq 131I-rituximab in either treatment weeks 1, 3 and 7 (two patients) or weeks 2, 4 and 8 (two patients). The 12 radiolabelled antibody injections were followed by three whole-body (WB) scintigraphic studies during 1 week and blood sampling on the same occasions. Additional WB scans were performed after 2 and 4 weeks post 131I-rituximab injection prior to the second and third injections, respectively.A single exponential radioactivity decrease for WB, liver, spleen, kidneys and heart was observed. Biodistribution and half-lives were patient specific, and without significant change after the second or third injection compared with the first one. Blood T(1/2)beta, calculated from the sequential blood samples and fitted to a bi-exponential curve, was similar to the T(1/2) of heart and liver but shorter than that of WB and kidneys. Effective radiation dose calculated from attenuation-corrected WB scans and blood using Mirdose3.1 was 0.53+0.05 mSv/MBq (range 0.48-0.59 mSv/MBq). Radiation dose was highest for spleen and kidneys, followed by heart and liver.These results show that the biodistribution and tissue kinetics of 131I-rituximab, while specific to each patient, remained constant during unlabelled antibody therapy. RIT radiation doses can therefore be reliably extrapolated from a preceding dosimetry study." @default.
• W2164634909 created "2016-06-24" @default.
• W2164634909 creator A5002739677 @default.
• W2164634909 creator A5006161033 @default.
• W2164634909 creator A5008423807 @default.
• W2164634909 creator A5013411479 @default.
• W2164634909 creator A5026331087 @default.
• W2164634909 creator A5055969947 @default.
• W2164634909 creator A5067504523 @default.
• W2164634909 creator A5076375585 @default.
• W2164634909 creator A5079761251 @default.
• W2164634909 creator A5090370995 @default.
• W2164634909 date "2005-04-12" @default.
• W2164634909 modified "2023-09-26" @default.
• W2164634909 title "Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics" @default.
• W2164634909 cites W125344597 @default.
• W2164634909 cites W1573890015 @default.
• W2164634909 cites W1950173032 @default.
• W2164634909 cites W1965280443 @default.
• W2164634909 cites W1983649348 @default.
• W2164634909 cites W1995325395 @default.
• W2164634909 cites W2052000503 @default.
• W2164634909 cites W2058426435 @default.
• W2164634909 cites W2063708816 @default.
• W2164634909 cites W206701898 @default.
• W2164634909 cites W2077147663 @default.
• W2164634909 cites W2080416356 @default.
• W2164634909 cites W2089056140 @default.
• W2164634909 cites W2091016562 @default.
• W2164634909 cites W2104940816 @default.
• W2164634909 cites W2111954560 @default.
• W2164634909 cites W2118334991 @default.
• W2164634909 cites W2150966373 @default.
• W2164634909 cites W2168750246 @default.
• W2164634909 cites W2171140185 @default.
• W2164634909 cites W2263072692 @default.
• W2164634909 cites W2279675890 @default.
• W2164634909 cites W2289534699 @default.
• W2164634909 cites W2348973547 @default.
• W2164634909 cites W2413718350 @default.
• W2164634909 cites W2414597488 @default.
• W2164634909 cites W60759546 @default.
• W2164634909 doi "https://doi.org/10.1007/s00259-005-1798-8" @default.
• W2164634909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15824926" @default.
• W2164634909 hasPublicationYear "2005" @default.
• W2164634909 type Work @default.
• W2164634909 sameAs 2164634909 @default.
• W2164634909 citedByCount "8" @default.
• W2164634909 countsByYear W21646349092013 @default.
• W2164634909 countsByYear W21646349092014 @default.
• W2164634909 countsByYear W21646349092022 @default.
• W2164634909 crossrefType "journal-article" @default.
• W2164634909 hasAuthorship W2164634909A5002739677 @default.
• W2164634909 hasAuthorship W2164634909A5006161033 @default.
• W2164634909 hasAuthorship W2164634909A5008423807 @default.
• W2164634909 hasAuthorship W2164634909A5013411479 @default.
• W2164634909 hasAuthorship W2164634909A5026331087 @default.
• W2164634909 hasAuthorship W2164634909A5055969947 @default.
• W2164634909 hasAuthorship W2164634909A5067504523 @default.
• W2164634909 hasAuthorship W2164634909A5076375585 @default.
• W2164634909 hasAuthorship W2164634909A5079761251 @default.
• W2164634909 hasAuthorship W2164634909A5090370995 @default.
• W2164634909 hasBestOaLocation W21646349092 @default.
• W2164634909 hasConcept C112705442 @default.
• W2164634909 hasConcept C126322002 @default.
• W2164634909 hasConcept C126894567 @default.
• W2164634909 hasConcept C150903083 @default.
• W2164634909 hasConcept C159654299 @default.
• W2164634909 hasConcept C203014093 @default.
• W2164634909 hasConcept C207001950 @default.
• W2164634909 hasConcept C2776146153 @default.
• W2164634909 hasConcept C2777807558 @default.
• W2164634909 hasConcept C2779338263 @default.
• W2164634909 hasConcept C2780653079 @default.
• W2164634909 hasConcept C2989005 @default.
• W2164634909 hasConcept C542903549 @default.
• W2164634909 hasConcept C71924100 @default.
• W2164634909 hasConcept C86803240 @default.
• W2164634909 hasConcept C90924648 @default.
• W2164634909 hasConceptScore W2164634909C112705442 @default.
• W2164634909 hasConceptScore W2164634909C126322002 @default.
• W2164634909 hasConceptScore W2164634909C126894567 @default.
• W2164634909 hasConceptScore W2164634909C150903083 @default.
• W2164634909 hasConceptScore W2164634909C159654299 @default.
• W2164634909 hasConceptScore W2164634909C203014093 @default.
• W2164634909 hasConceptScore W2164634909C207001950 @default.
• W2164634909 hasConceptScore W2164634909C2776146153 @default.
• W2164634909 hasConceptScore W2164634909C2777807558 @default.
• W2164634909 hasConceptScore W2164634909C2779338263 @default.
• W2164634909 hasConceptScore W2164634909C2780653079 @default.
• W2164634909 hasConceptScore W2164634909C2989005 @default.
• W2164634909 hasConceptScore W2164634909C542903549 @default.
• W2164634909 hasConceptScore W2164634909C71924100 @default.
• W2164634909 hasConceptScore W2164634909C86803240 @default.
• W2164634909 hasConceptScore W2164634909C90924648 @default.
• W2164634909 hasIssue "8" @default.
• W2164634909 hasLocation W21646349091 @default.
• W2164634909 hasLocation W21646349092 @default.

• next